This brand name is authorized in Spain.
The drug SALMAGNE contains a combination of these active pharmaceutical ingredients (APIs):
1
|
UNII
8MDF5V39QO - SODIUM BICARBONATE
|
|
Sodium bicarbonate has antacid properties. Sodium bicarbonate causes neutralisation of gastric acid with the production of carbon dioxide. |
|
2
|
UNII
W4888I119H - TARTARIC ACID
|
3
|
UNII
3OWL53L36A - MANNITOL
|
|
Mannitol is a naturally occurring sugar alcohol used clinically primarily for its osmotic diuretic properties. |
|
4
|
UNII
DE08037SAB - MAGNESIUM SULFATE, UNSPECIFIED FORM
|
|
Magnesium sulfate is a saline purgative. It can be employed locally in various inflammatory conditions, due to its osmotic action. |
|
5
|
UNII
RHO26O1T9V - MAGNESIUM CITRATE
|
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| A06AD10 | Mineral salts in combination | A Alimentary tract and metabolism → A06 Laxatives → A06A Laxatives → A06AD Osmotically acting laxatives |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| ES | Centro de información online de medicamentos de la AEMPS | 42411 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.